While limited previous studies had only assessed PAX8 expression in mucinous carcinomas (10/25; 40% expression) [64], a recent study confirmed expression of PAX8 in MBT (14/23; 61%) as well as ovarian mucinous carcinomas (11/24; 46%). Here, PAX8 is linked to ovarian mucinous adenocarcinoma.